Articles with public access mandates - Euan StronachLearn more
Not available anywhere: 3
Whole–genome characterization of chemoresistant ovarian cancer
AM Patch, EL Christie, D Etemadmoghadam, DW Garsed, J George, ...
Nature 521 (7553), 489-494, 2015
Mandates: National Health and Medical Research Council, Australia, Cancer Research UK …
Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells
N Chapman-Rothe, E Curry, C Zeller, D Liber, E Stronach, H Gabra, ...
Oncogene 32 (38), 4586-4592, 2013
Mandates: A*Star, Singapore, Cancer Research UK
Evaluation of 2-Deoxy-2-[18F]Fluoro-D-glucose- and 3′-Deoxy-3′-[18F]Fluorothymidine–Positron Emission Tomography as Biomarkers of Therapy Response in …
M Perumal, EA Stronach, H Gabra, EO Aboagye
Molecular Imaging and Biology 14, 753-761, 2012
Mandates: Cancer Research UK
Available somewhere: 23
Rethinking ovarian cancer: recommendations for improving outcomes
S Vaughan, JI Coward, RC Bast Jr, A Berchuck, JS Berek, JD Brenton, ...
Nature Reviews Cancer 11 (10), 719-725, 2011
Mandates: US National Institutes of Health, Cancer Research UK
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ...
Nature reviews Cancer 15 (11), 668-679, 2015
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
FM Behan, F Iorio, G Picco, E Gonçalves, CM Beaver, G Migliardi, ...
Nature 568 (7753), 511-516, 2019
Mandates: Wellcome Trust, European Commission, Government of Italy
HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer
EA Stronach, A Alfraidi, N Rama, C Datler, JB Studd, R Agarwal, ...
Cancer research 71 (13), 4412-4422, 2011
Mandates: US National Institutes of Health, Cancer Research UK
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer
DS Matassa, MR Amoroso, H Lu, R Avolio, D Arzeni, C Procaccini, ...
Cell Death & Differentiation 23 (9), 1542-1554, 2016
Mandates: European Commission, Government of Italy
DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance
EA Stronach, M Chen, EN Maginn, R Agarwal, GB Mills, H Wasan, ...
Neoplasia 13 (11), 1069-IN35, 2011
Mandates: US National Institutes of Health, Cancer Research UK
Prognostic gene expression signature for high-grade serous ovarian cancer
J Millstein, T Budden, EL Goode, MS Anglesio, A Talhouk, ...
Annals of Oncology 31 (9), 1240-1250, 2020
Mandates: US Department of Defense, US National Institutes of Health, National Health …
Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening
G Picco, ED Chen, LG Alonso, FM Behan, E Gonçalves, G Bignell, ...
Nature communications 10 (1), 2198, 2019
Mandates: UK Medical Research Council
Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following …
EA Stronach, J Paul, KM Timms, E Hughes, K Brown, C Neff, M Perry, ...
Molecular Cancer Research 16 (7), 1103-1111, 2018
Mandates: Cancer Research UK, National Institute for Health Research, UK
Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival
W Dai, JM Teodoridis, C Zeller, J Graham, J Hersey, JM Flanagan, ...
Clinical Cancer Research 17 (12), 4052-4062, 2011
Mandates: Cancer Research UK
Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
F Iorio, FM Behan, E Gonçalves, SG Bhosle, E Chen, R Shepherd, ...
BMC genomics 19, 1-16, 2018
Mandates: Cancer Research UK, Wellcome Trust
Microarray coupled to quantitative RT–PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells
S Ngan, EA Stronach, A Photiou, J Waxman, S Ali, L Buluwela
Oncogene 28 (19), 2051-2063, 2009
Mandates: Cancer Research UK
MicroRNAs associated with small bowel neuroendocrine tumours and their metastases
HC Miller, AE Frampton, A Malczewska, S Ottaviani, EA Stronach, R Flora, ...
Endocr Relat Cancer 23 (9), 711-726, 2016
Mandates: Cancer Research UK, National Institute for Health Research, UK
The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma
EA Stronach, P Cunnea, C Turner, T Guney, R Aiyappa, S Jeyapalan, ...
Oncotarget 6 (31), 31593, 2015
Mandates: National Institute for Health Research, UK
Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE)
A Talhouk, J George, C Wang, T Budden, TZ Tan, DS Chiu, S Kommoss, ...
Clinical Cancer Research 26 (20), 5411-5423, 2020
Mandates: US Department of Defense, US National Institutes of Health, National Health …
Phase IB dose escalation and expansion study of AKT inhibitor afuresertib with carboplatin and paclitaxel in recurrent platinum-resistant ovarian cancer
SP Blagden, AL Hamilton, L Mileshkin, S Wong, A Michael, M Hall, ...
Clinical Cancer Research 25 (5), 1472-1478, 2019
Mandates: Cancer Research UK
Structural rearrangements generate cell-specific, gene-independent CRISPR-Cas9 loss of fitness effects
E Gonçalves, FM Behan, S Louzada, D Arnol, EA Stronach, F Yang, ...
Genome biology 20, 1-10, 2019
Mandates: Cancer Research UK, Wellcome Trust
Publication and funding information is determined automatically by a computer program